Medifast appoints Nicholas Johnson as CEO; Dan Chard becomes non-executive Chairman

MEDIFAST INC

Nicholas Johnson, 46, becomes CEO effective June 1, 2026; Dan Chard transitions to non-executive Chairman.
Johnson's compensation: $600K base salary, target bonus 100% of base, LTI target 250% of base (69% increase vs. prior role).
Stockholders approved Amended 2012 Share Incentive Plan, increasing authorized shares by 250,000.
All seven director nominees elected; say-on-pay and auditor ratification passed.
Johnson joined Medifast in 2018, most recently as President; prior senior roles at Nu Skin Enterprises.

item 5.02 item 5.07 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001628280-26-038109
form_type: 8-K
ticker: MED
cik: 0000910329
company_name: MEDIFAST INC
filed_at: 2026-05-26T20:26:14+00:00
discovered_at: 2026-05-26T20:27:01.397105+00:00
generated_at: 2026-05-26T20:30:17.319413+00:00
sec_items: ["5.02", "5.07", "7.01", "9.01"]
event_type: leadership
sentiment: neutral
materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001628280-26-038109
json_url: https://secwatch.observer/filing/0001628280-26-038109.json
markdown_url: https://secwatch.observer/filing/0001628280-26-038109.md
text_url: https://secwatch.observer/filing/0001628280-26-038109.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/910329/000162828026038109/0001628280-26-038109-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/910329/000162828026038109/med-20260519.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Nicholas Johnson

Chief Executive Officer

MED · MEDIFAST INC

Effective: 2026-06-01
Filed: May 26, 2026 20:26 UTC

On May 20, 2026, the Board appointed Nicholas Johnson, age 46, to serve as Chief Executive Officer of the Company, effective June 1, 2026.

Source-grounded claims

8ad070441e

Nicholas Johnson was appointed as Chief Executive Officer at MEDIFAST INC.

On May 20, 2026, the Board appointed Nicholas Johnson, age 46, to serve as Chief Executive Officer of the Company, effective June 1, 2026.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

Source: SEC EDGAR

accession 0001628280-26-038109

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.